Oncovask is dedicated to identifying and validating novel biomarkers for cancer detection, prognosis, and treatment response. This involves in-depth analysis of various molecular, genetic, and protein-based markers to uncover new indicators that can aid in early diagnosis, predict disease progression, and guide therapeutic decisions.